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http://www.biomedcentral.com/1471-230X/13/46RESEARCH ARTICLE Open AccessPathogen-specific risk of chronic gastrointestinal
disorders following bacterial causes of foodborne
illness
Chad K Porter1*, Daniel Choi2, Brooks Cash3, Mark Pimentel4, Joseph Murray5, Larissa May2 and Mark S Riddle1Abstract
Background: The US CDC estimates over 2 million foodborne illnesses are annually caused by 4 major
enteropathogens: non-typhoid Salmonella spp., Campylobacter spp., Shigella spp. and Yersinia enterocoltica. While
data suggest a number of costly and morbid chronic sequelae associated with these infections, pathogen-specific
risk estimates are lacking. We utilized a US Department of Defense medical encounter database to evaluate the risk
of several gastrointestinal disorders following select foodborne infections.
Methods: We identified subjects with acute gastroenteritis between 1998 to 2009 attributed to Salmonella
(nontyphoidal) spp., Shigella spp., Campylobacter spp. or Yersinia enterocolitica and matched each with up to 4
unexposed subjects. Medical history was analyzed for the duration of military service time (or a minimum of 1 year)
to assess for incident chronic gastrointestinal disorders. Relative risks were calculated using modified Poisson
regression while controlling for the effect of covariates.
Results: A total of 1,753 pathogen-specific gastroenteritis cases (Campylobacter: 738, Salmonella: 624, Shigella: 376,
Yersinia: 17) were identified and followed for a median of 3.8 years. The incidence (per 100,000 person-years) of PI
sequelae among exposed was as follows: irritable bowel syndrome (IBS), 3.0; dyspepsia, 1.8; constipation, 3.9;
gastroesophageal reflux disease (GERD), 9.7. In multivariate analyses, we found pathogen-specific increased risk of
IBS, dyspepsia, constipation and GERD.
Conclusions: These data confirm previous studies demonstrating risk of chronic gastrointestinal sequelae following
bacterial enteric infections and highlight additional preventable burden of disease which may inform better food
security policies and practices, and prompt further research into pathogenic mechanisms.Background
Infectious gastroenteritis (IGE) is caused by a myriad of
viruses, bacteria and parasites. Approximately 47.8 mil-
lion foodborne-related illnesses occur annually in the
United States, costing upwards of $150 million to the
healthcare economy [1,2]. The four major bacterial
enteropathogens responsible for morbidity and morta-
lity include non-typhoidal Salmonella, Campylobacter,
Shigella, and Yersinia enterocolitica [2]. In addition to
the significant burden of the acute illness associated with
these infections, recent evidence suggests that these
pathogens are linked with chronic health sequelae,* Correspondence: chad.porter@med.navy.mil
1Enteric Diseases Department, Naval Medical Research Center, Silver Spring,
MD, USA
Full list of author information is available at the end of the article
© 2013 Porter et al.; licensee BioMed Central L
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reproduction in any medium, provided the orincluding functional gastrointestinal disorders (FGD)
such as irritable bowel syndrome (IBS), functional
constipation, and functional dyspepsia [3-8]. As a het-
erogeneous complex of disorders, FGD account for
approximately 50% of all visits to gastroenterology prac-
tices and result in significant morbidity in the affected
patient [9,10]. Additionally, these disorders result in sig-
nificant financial burden, with annual costs per case ran-
ging from $1,000-$5000 in the US [11-16]. Furthermore,
such infections have been associated with inflammatory
bowel disease [17-19], celiac disease [20,21], and func-
tional dyspepsia [3,22-24] which share symptom overlap
with gastroesophageal reflux disease (GERD) [25].
While numerous studies have reported on post-
infectious FGD (PI-FGD), studies of pathogen-specific
associations are limited. Such data are important,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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risks in order to develop mitigating policies and prac-
tices, as well as to understand pathogenic mechanisms
of PI-FGD. Thus, we sought to evaluate the risk of select
chronic gastrointestinal consequences following illness
attributed to non-typhoid Salmonella, Campylobacter,
Shigella, and Yersinia enterocolitica in a young, predom-
inately healthy subset of the US population.
Methods
This was a retrospective cohort study in which the med-
ical records of subjects diagnosed with non-typhoidal
Salmonella spp., Shigella spp., Campylobacter spp., or
Yersinia enterocolitica were assessed with the onset of
FGD and GERD. Data were obtained from the Armed
Forces Health Surveillance Center (AFHSC), which over-
sees the Defense Department Medical Surveillance Sys-
tem (DMSS), the main data repository for all medical
encounters of active duty US military personnel.
Medical encounter history on all subjects with an
inpatient or outpatient visit in which one of the follow-
ing (International Classification of Diseases, 9th Revision)
ICD-9 codes were assigned was obtained: Salmonella
(003.0 and 003.9), Shigella (004), Campylobacter
(008.43) and Yersinia enterocolitica (008.44). Subjects
with one of the foodborne illnesses identified above were
matched by age, gender, number of deployments,
medical treatment facility, encounter type (inpatient,
outpatient) and time, to up to 4 subjects without a docu-
mented gastrointestinal infection. Baseline diagnoses of
unexposed subjects included: acute respiratory infec-
tions, pneumonia and influenza, infections of skin and
subcutaneous tissue, dislocations, sprains and strains for
joints and adjacent muscles, superficial injury, burns,
and fracture of the upper or lower limb.
Incident FGD and GERD were similarly identified
using medical encounters with specific ICD-9 codes
in any diagnostic position as follows: constipation
(656.0), irritable bowel syndrome (564.1, 306.4), dyspep-
sia (536.8), and GERD (530.81). Other covariates
obtained included race, military rank, socioeconomic
factors (level of education, marital status), and Axis I
and Axis II psychological conditions. All subjects with
antecedent FGD or GERD diagnoses were excluded.
A modified Poisson regression analysis was used for
data analysis with a robust sandwich estimator for vari-
ance [26]. Associations were initially explored by univar-
iate methods. Multivariate models were utilized to assess
the association between foodborne illness and FGD
while controlling for important covariates. Initial models
were developed utilizing all exposed subjects using a
backwards elimination approach with an alpha of 0.15.
Those models were then applied to pathogen-specific
exposures. Two-tailed significance was evaluated usingan alpha of 0.05. All analyses were performed using SAS
8.2 (Cary, NC).
The study protocol was approved by the Naval Med-
ical Research Center Institutional Review Board (study
protocol NMRC.2011.0003) in compliance with all ap-
plicable Federal regulations governing the protection of
human subjects.
Results
We identified 1,753 active duty US military personnel
diagnosed with one of the four pathogens of interest
(Campylobacter: 738, Salmonella: 624, Shigella: 376,
Y. enterocolitica: 17) between 1998 and 2009 (Table 1).
A total of 6,765 subjects were included in the referent
cohort with baseline diagnoses that included respiratory
or skin infections, sprains, strains, dislocations and frac-
tures, superficial injuries and burns. In general, the
demographics of the study population were representa-
tive of the active duty military population in terms of
race (68.5% Caucasian), education (62% with only a high
school education or equivalent), branch of service
(31.1% Navy, 27.3% Army, 26.7% Air Force, 10.1% Ma-
rines, and 4.7% Coast Guard), rank (81.7% enlisted), and
marital status (69% married). However, a higher propor-
tion of Navy personnel were included in the referent
cohort than in subjects with documented bacterial
gastroenteritis (34.5% and 17.8%, respectively; p < 0.001).
The median follow-up duration was 3.8 (interquartile
range [IQR]: 2.1, 6.7) years, totaling 38,844 person-years
of observation. A greater proportion of exposed Army
personnel had bacterial IGE during the study period
(45.0% for those exposed compared to 2.4 – 27.7% for
the other branches of service, respectively; p < 0.001).
The most common outcome was GERD (n = 943)
followed by functional constipation (n = 373), IBS
(n = 203) and dyspepsia (n = 190). The incidence (per
100,000 person-years) of each of these outcomes strati-
fied by exposure is shown in Table 2. We saw a consist-
ently higher incidence of FGD and GERD for those with
prior IGE compared to the referent cohort. The stron-
gest association was for IBS with Y. enterocolitica dem-
onstrating the greatest relative risk (aRR: 13.1; 95%
confidence interval [CI]: 4.4, 39.4). Functional dyspepsia
showed only a weak association with bacillary diarrhea
(Table 3).
We also noted variability in effect estimates across
pathogen type. The highest adjusted relative risk for IBS
was associated with prior Y. enterocolitica infection
(aRR: 13.1; 95% CI: 4.4, 39.4); however, the number
of cases was small. Y. enterocolitica also conferred sig-
nificant risk for functional constipation (aRR: 4.4; 95%
CI: 1.2, 15.4). The greatest pathogen variability occurred
for the diagnosis of dyspepsia, ranging from an adjusted
relative risk of 0.6 for Shigella (95% CI: 0.2, 1.3) to 2.0
Table 1 Demographics of a cohort of U.S. military service members exposed with bacterial gastroenteritis infections
and a matched (age, gender, deployment, baseline medical encounter) cohort of subjects without gastroenteritis
Exposed Unexposed
Any bacillary
diarrhea
Campylobacter
spp.
Non-typhoid Salmonella
spp.
Shigella
spp.
Yersinia
enterocolitica
N 1753 738 624 376 17 6765
Median age (IQR) 28 (23,34) 29 (24,36) 26 (22,32) 29 (25,35) 27 (23,33) 28 (23,34)
Race [n (%)]
White, Non-Hispanic 1264 (72.1) 584 (79.1) 424 (68.0) 242 (64.4) 16 (95.1) 4570 (67.6)
African-American 275 (15.7) 58 (7.9) 119 (19.1) 97 (25.8) 1 (5.9) 1291 (19.1)
Other 214 (12.2) 96 (13.0) 81 (13.0) 37 (9.8) 0 (0.0) 904 (13.4)
Sex [n (%)]
Male 1419 (81.0) 624 (84.6) 496 (79.5) 287 (76.3) 14 (82.4) 5506 (81.4)
Female 334 (19.1) 114 (15.5) 128 (20.5) 89 (23.7) 3 (17.7) 1259 (18.6)
Branch of Service [n
(%)]
Army 789 (45.0) 378 (51.2) 252 (40.4) 153 (40.7) 8 (47.1) 1540 (22.8)
Marine 124 (7.1) 41 (5.6) 58 (9.3) 23 (6.1) 2 (11.8) 739 (10.9)
Navy 312 (17.8) 106 (14.4) 136 (21.8) 68 (18.1) 2 (11.8) 2336 (34.5)
Air Force 486 (27.7) 204 (27.6) 152 (24.4) 125 (33.2) 5 (29.4) 1790 (26.5)
Coast Guard 42 (2.4) 9 (1.2) 26 (4.2) 7 (1.9) 0 (0.0) 360 (5.3)
Education [n (%)]
No High School 12 (0.7) 2 (0.3) 5 (0.8) 5 (1.3) 0 (0.0) 36 (0.5)
High School 961 (54.9) 357 (48.4) 378 (60.6) 213 (56.7) 14 (82.4) 4272 (63.2)
Less than 4 yrs of
College
228 (13.0) 99 (13.4) 79 (12.7) 51 (13.6) 0 (0.0) 731 (10.8)
Bachelor’s Degree 257 (14.7) 121 (16.4) 84 (13.5) 51 (13.5) 1 (5.9) 819 (12.1)
Graduate Degree 234 (13.4) 135 (18.3) 54 (8.7) 44 (11.7) 1 (5.9) 628 (9.3)
Unknown 61 (3.5) 24 (3.3) 24 (3.9) 12 (3.2) 1 (5.9) 279 (4.1)
Marital Status [n (%)]
Single, Never Married 347 (19.8) 129 (17.5) 153 (24.5) 61 (16.2) 5 (29.4) 1892 (28.0)
Married 1278 (72.9) 560 (75.9) 429 (68.8) 281 (74.7) 9 (52.9) 4564 (67.5)
Other 126 (7.2) 49 (6.6) 41 (6.6) 33 (8.8) 3 (17.7) 309 (4.6)
Unknown 2 (0.1) 0 (0.0) 1 (0.2) 1 (0.3) 0 (0.0) 0 (0.0)
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was a more rapid rate of meeting the case definition,
specifically for IBS, across all exposure types (Figure 1).
Across the pathogen-specific exposures, GERD diag-
noses commonly overlapped functional GI disordersTable 2 Incidence (95% confidence interval) of chronic health
cohort or following documented bacillary diarrhea attributab
among active duty U.S. military personnel from 1998 to 2009
Any bacterial IGE Salmonella
Irritable bowel syndrome 3.0 (2.5, 3.7) 3.1 (2.2, 4.4)
Functional Constipation 3.9 (3.2, 4.6) 3.4 (2.5, 4.7)
Functional Dyspepsia 1.8 (1.3, 2.3) 1.4 (0.9, 2.3)
GERD 9.7 (8.6, 10.9) 8.4 (6.8, 10.4)(Table 4). This overlap was more common amongst the
exposed subjects, where 48.3% of IBS-diagnosed individ-
uals also received a diagnosis of GERD during their
follow-up compared to only 34.2% in unexposed subjects
(p = 0.04). Similarly, amongst exposed subjects withoutcomes per 100,000 person-years in a reference
le to Salmonella, Campylobacter, Shigella or Yersinia
Campylobacter Shigella Yersinia Unexposed
2.9 (2.1, 4.0) 2.6 (1.6, 4.1) 13.2 (4.4, 39.7) 1.0 (0.9, 1.2)
4.0 (3.0, 5.2) 4.2 (2.9, 6.1) 8.5 (2.6, 28.0) 2.3 (2.1, 2.6)
2.6 (1.9, 3.7) 0.8 (0.3, 1.8) – 1.2 (1.0, 1.5)
10.9 (9.2, 12.9) 9.5 (7.4, 12.2) 13.9 (4.8, 40.5) 6.2 (5.8, 6.7)
Table 3 Unadjusted and adjusted1 relative risk (with 95% confidence intervals) of chronic health outcomes following
documented bacillary diarrhea attributable to Salmonella, Campylobacter, Shigella, and Yersinia among active duty U.
S. military personnel from 1998 to 2009
All bacterial IGE Salmonella Campylobacter Shigella Yersinia
Unadjusted effect estimates IBS 2.9 (2.2, 3.8) 3.0 (2.0, 4.4) 2.9 (2.0, 4.1) 2.5 (1.5, 4.2) 12.8 (4.2, 39.3)
Functional Dyspepsia 1.4 (1.0, 2.0) 1.2 (0.7, 2.0) 2.1 (1.5, 3.1) 0.6 (0.3, 1.5) –
Functional Constipation 1.7 (1.3, 2.1) 1.5 (1.1,2.1) 1.7 (1.3, 2.3) 1.8 (1.2, 2.6) 3.6 (1.1, 12.1)
GERD 1.6 (1.4, 1.8) 1.4 (1.1, 1.7) 1.8 (1.5, 2.1) 1.5 (1.2, 2.0) 2.2 (0.8, 6.5)
Adjusted effect estimates1 IBS 2.7 (2.1, 3.6) 2.8 (1.9, 4.2) 2.8 (1.9, 4.1) 2.3 (1.4, 3.9) 13.1 (4.4, 39.4)
Functional Dyspepsia 1.3 (1.0, 1.9) 1.1 (0.6, 1.9) 2.0 (1.3, 3.0) 0.6 (0.2, 1.3) –
Functional Constipation 1.6 (1.3, 2.0) 1.4 (1.0, 1.9) 1.8 (1.3, 2.5) 1.6 (1.1, 2.4) 4.4 (1.2, 15.4)
GERD 1.6 (1.4, 1.8) 1.5 (1.2, 1.8) 1.7 (1.4, 2.1) 1.5 (1.1, 1.9) 2.3 (0.8, 6.9)
1 Effect estimates were adjusted for specific covariates as follows:
IBS: branch of military service, ethnicity, gender.
Dyspepsia: marital status, branch of military service, gender, age at initiation of surveillance.
Functional constipation: marital status, military rank, branch of military service, sex, age at initiation of surveillance.
GERD: marital status, military rank, gender.
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compared to only 24.8% who were unexposed (p = 0.02).
Discussion
Our results support an accumulating body of epidemio-
logical evidence for post bacterial gastroenteritis risk for
FGD, including IBS, functional dyspepsia, and constipa-
tion, as well as GERD, which to our knowledge is an
unrecognized putative sequel of IGE. Similar to prior
studies, our results show a significantly increased risk
of FGD among those with antecedent bacterial IGE
[3,23,24,27,28]. Additionally, we observed variability in
effect estimates across pathogens. Specifically, we found
a greater risk of FGD in those with prior Y. enterocolitica
infection than what was observed with other bacterial
enteropathogens. Prior studies have documented aFigure 1 Time to IBS onset following documented bacillary diarrhea a
among active duty U.S. military personnel from 1998 to 2009.history of Y. enterocolitica infection in adults and chil-
dren with persistent abdominal pain and other GI com-
plaints [29,30]. In a 2004 follow-up study of laboratory
confirmed enteric infections, 9.3% of survey respondents
reported persistent GI symptoms following recovery
from acute illness [31]. This proportion was higher for
Y. enterocolitica (25%) than for Campylobacter (8.6%),
Salmonella (8.0%), or Shigella (6.2%), although the over-
all response rate was low.
Y. enterocolitica is also known to cause granulomatous
disease and thus may be a stronger trigger for subsequent
immune dysregulation [32]. The association between FGD
and antecedent IGE has been reported in several inde-
pendent studies and systematic reviews [27,33]. In con-
trast to the published literature, the magnitude of
increased risk reported here was lower than prior studies,ttributable to Salmonella, Campylobacter, Shigella, and Yersinia
Table 4 Overlap of diagnosed outcomes following documented bacillary diarrhea attributable to Salmonella,
Campylobacter, Shigellacpa and Yersinia and an unexposed reference cohort
Cohort Outcome IBS Functional constipation GERD Functional dyspepsia
Exposed IBS 100% 22.5% 48.3% 11.2%
Functional Constipation – 100% 36.5% 10.4%
GERD – – 100% 11.6%
Unexposed IBS 100% 21.1% 34.2% 10.5%
Functional Constipation – 100% 24.8% 7.4%
GERD – – 100% 11.5%
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and outcome ascertainment. However, this is the first
study to report variable pathogen-specific risks across four
common bacterial enteropathogens in a single population.
Variability in the site of infection, method of invasion, and
induction of the host immune responses due to these four
enteropathogens are all possible contributors to the ob-
served variability [34].
Studies of non-IBS PI-FGD are limited, although there
are increasing reports on the risk of functional dyspepsia
following acute enteric infection [3,5,23]. We recently
reported an increased risk of FGD sequelae following
all-cause IGE not limited to specific bacterial etiologies
[6,7]. While the effect estimates here are lower than pre-
viously reported, they are in the same direction, and
variability may be due to the pathogens studied, sample
population, or other methodological differences. Despite
the accumulating evidence linking IGE with functional
dyspepsia, studies on the post-infectious risk of GERD
are lacking. Thus, our finding of an association of enteric
bacterial pathogen exposure with an incident diagnosis
of GERD is, to our knowledge, a novel finding requiring
further exploration. A complicating factor here is the
diagnosis of GERD which can be distinguished by a var-
iety of modalities including therapeutic trial, endoscopy,
esophageal acid and motility testing, and gastric empty-
ing studies [35]. Our outcome based on medical encoun-
ter ICD9-CM did not allow for verification of cases
based on differential diagnostic criteria. Interestingly, our
effect estimates of functional dyspepsia and GERD are
similar, suggesting diagnostic misclassification of upper
gastrointestinal dysfunction, or similar pathoetiological
mechanisms resulting in these gastroduodenal disorders.
Also problematic in evaluating causation is the possibility
that individuals may have used antacid medications (pre-
scription or over-the-counter) for symptoms preceding
their GERD diagnosis, which could have increased suscepti-
bility to IGE and confounded the association between IGE
and GERD. Confirmatory studies utilizing better-defined
diagnostic criteria, database case-validation methods, and
control of concomitant medications are needed.
We noted a significant amount of overlap in many of
the outcomes; however, overlaps appeared to be morefrequent among subjects with an antecedent bacillary
diarrhea compared with those who were unexposed.
Prior studies on post-infectious IBS following gastro-
enteritis attributed to non-typhoid Salmonella have
pointed to an overlap with dyspepsia [23] and an in-
creased risk of PI-dyspepsia has been reported following
numerous IGE exposures [3,6-8,24,36]. While FGDs are
often characterized by the Rome criteria [37], such clas-
sification may be insufficient at characterizing the true
phenotypic classification and symptom complex seen
in patients with PI-FGD. Future studies to better
characterize the outcome of PI-FGD are needed to ex-
pand the phenotypic attributes of these functional out-
comes following IGE.
A number of clinical features have previously been
shown to be risk modifiers for PI-FGD including severity
of disease, sex, use of antibiotics, psychological comor-
bidities, acute stress, and duration of illness [38-40]. The
medical encounter data utilized precluded any clinical
symptom-based severity of disease assessment, however
we did not identify sex as an important covariate across
the FGD models. Furthermore, we were also able to evalu-
ate the potential influence of comorbid psychological con-
ditions on both host susceptibility to enteric infection, as
well as the potentiation of FGD after enteric infection. No
association between diagnosed psychological disorders
and FGD risk in this study was identified (data not
shown), possibly due to the reliance on diagnosed mental
health conditions instead of self-reported conditions. Sev-
eral prior studies have identified an association between
stressful events prior to infectious episodes and the subse-
quent risk of FGD [41,42]. However, we were unable
to assess undiagnosed stressors or other psychosocial
comorbidities prior to either exposure or outcome.
Interpretation of these results should be done with a
full appreciation of potential biases inherent with med-
ical encounter database studies, as well as the population
under study. Active duty military personnel are younger
and generally healthier than other adults, therefore the
associations and effect estimates may not be generalizable
to other populations. Secondly, because we relied on
ICD-9 codes and reportable disease notification data ra-
ther than actual laboratory confirmation, we cannot
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though presumably a pathogen-specific ICD-9 would not
be coded without confirmation. Because our data set did
not include pharmacy data or survey-based symptom as-
sessment, we could not completely control for pre-
existing functional symptoms, nor the use of proton pump
inhibitors, antacids, or other medications, which may have
confounded the observed associations with both exposure
and outcomes [43]. An attempt was made to control for
diagnosed medical conditions in which acid suppressive
medication would be used (e.g. peptic ulcer disease,
Barrett’s esophagus); however, future studies are needed to
control for actual medication usage and pre-existing con-
ditions. Similarly, the use of antibiotics for IGE treatment
may have increased exposed subjects’ risk of FGDs; which,
as previously described, may be confounded by subjects
with more severe clinical illness [40].Conclusions
Despite the noted limitations, we have confirmed an in-
creased risk of FGDs following infection with unique
bacterial enteropathogens. Recent reports on the signifi-
cant costs and morbidity associated with the acute dis-
ease attributable to foodborne illness [44,45], and the
significant costs and decrements in health-related quality
of life associated with the long-term health outcomes
reported here [11,12,15,16,46], highlight the need for
continued efforts to improve primary prevention strat-
egies and to better understand the etiology underlying
the differential pathogen-specific risks. While additional
study is needed, these results raise the specter of the
potential burden associated with these infections, and
highlight the need for primary prevention strategies and
optimized food safety policies in the US and globally.Consent
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